These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 14560492)

  • 41. Neuropsychologic functioning and structural MRI of the brain in patients with schizophrenia.
    Premkumar P; Sharma T
    Expert Rev Neurother; 2005 Jan; 5(1):85-94. PubMed ID: 15853478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dopamine hypothesis of schizophrenia revisited.
    van Kammen DP
    Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
    [No Abstract]   [Full Text] [Related]  

  • 43. The neurobiology of cognition in schizophrenia.
    Tamminga CA
    J Clin Psychiatry; 2006 Sep; 67(9):e11. PubMed ID: 17081078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. White matter abnormalities and neurocognitive deficits associated with the passivity phenomenon in schizophrenia: a diffusion tensor imaging study.
    Sim K; Yang GL; Loh D; Poon LY; Sitoh YY; Verma S; Keefe R; Collinson S; Chong SA; Heckers S; Nowinski W; Pantelis C
    Psychiatry Res; 2009 May; 172(2):121-7. PubMed ID: 19297135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.
    Kraguljac NV; White DM; Hadley N; Hadley JA; Ver Hoef L; Davis E; Lahti AC
    Schizophr Bull; 2016 Jul; 42(4):1046-55. PubMed ID: 26873890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of limbic and cortical regions in schizophrenia: focus on dopamine.
    Marchese G; Pani L
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():349s-354s. PubMed ID: 23573604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cortical microcircuits in schizophrenia--the dopamine hypothesis revisited.
    Winterer G
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S68-71. PubMed ID: 16508900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
    Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
    Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
    Mahadik SP; Pillai A; Joshi S; Foster A
    Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies.
    Brunet-Gouet E; Decety J
    Psychiatry Res; 2006 Dec; 148(2-3):75-92. PubMed ID: 17088049
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent diffusion tensor imaging findings in early stages of schizophrenia.
    Kyriakopoulos M; Frangou S
    Curr Opin Psychiatry; 2009 Mar; 22(2):168-76. PubMed ID: 19553871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schizophrenia in childhood and adolescence.
    Mala E
    Neuro Endocrinol Lett; 2008 Dec; 29(6):831-6. PubMed ID: 19112396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of neuroleptics in a attempt at understanding the vulnerability to schizophrenia].
    Meurice E
    Acta Psychiatr Belg; 1992; 92(6):339-54. PubMed ID: 1364282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroimaging studies of the hippocampus in schizophrenia.
    Heckers S
    Hippocampus; 2001; 11(5):520-8. PubMed ID: 11732705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The brain in schizophrenia.
    Hyde TM; Weinberger DR
    Semin Neurol; 1990 Sep; 10(3):276-86. PubMed ID: 2259806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling schizophrenia: uncovering novel therapeutic targets.
    Desbonnet L; O'Tuathaigh CM; Waddington JL
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):667-76. PubMed ID: 23234324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Progress in research on etiopathogenesis of schizophrenia in recent decades].
    Rybakowski J
    Psychiatr Pol; 1997; 31(5):513-26. PubMed ID: 9547178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Semi-mechanistic computer simulation of psychotic symptoms in schizophrenia with a model of a humanized cortico-striatal-thalamocortical loop.
    Spiros A; Roberts P; Geerts H
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):107-119. PubMed ID: 28062203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia.
    Csernansky JG; Bardgett ME
    Schizophr Bull; 1998; 24(2):231-48. PubMed ID: 9613623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.